Treatment advances in the management of oropharyngeal carcinoma: from minimally invasive surgery to target radiotherapy

[1]  K. Higgins,et al.  Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial. , 2022, JAMA oncology.

[2]  T. Fenton,et al.  HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management , 2022, Nature Reviews Clinical Oncology.

[3]  C. Buchwald,et al.  A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide , 2021, Viruses.

[4]  R. Fisher,et al.  Randomised trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01) - a Trans-Tasman Radiation Oncology Group study. , 2021, International journal of radiation oncology, biology, physics.

[5]  E. Genden,et al.  De-Escalated Adjuvant Therapy after Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial. , 2021, The oncologist.

[6]  G. Lawson,et al.  Anatomical‐based classification for transoral base of tongue resection , 2021, Head & neck.

[7]  R. Orecchia,et al.  IMRT vs 2D/3D conformal RT in oropharyngeal cancer: a review of the literature and meta-analysis. , 2020, Oral diseases.

[8]  A. De Virgilio,et al.  Transoral robotic surgery and intensity-modulated radiotherapy in the treatment of the oropharyngeal carcinoma: a systematic review and meta-analysis , 2020, European Archives of Oto-Rhino-Laryngology.

[9]  M. Scorsetti,et al.  Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma , 2020, Current Oncology Reports.

[10]  A. Del Mistro,et al.  Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East Italy , 2020, Scientific Reports.

[11]  J. Kasperbauer,et al.  One‐year outcomes for da Vinci single port robot for transoral robotic surgery , 2020, Head & neck.

[12]  A. Amini,et al.  De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials. , 2020, Oral oncology.

[13]  A. De Virgilio,et al.  Trans-oral robotic surgery in the management of parapharyngeal space tumors: A systematic review. , 2020, Oral oncology.

[14]  G. Weinstein,et al.  A Phase II Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed Following Transoral Robotic Surgery for Human Papilloma Virus Related Squamous Cell Carcinoma of the Oropharynx. , 2019, International journal of radiation oncology, biology, physics.

[15]  M. Remacle,et al.  Anatomical-based classification for transoral lateral oropharyngectomy. , 2019, Oral oncology.

[16]  H. Shukla,et al.  Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS). , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  P. Gorphe,et al.  A systematic review and meta-analysis of margins in transoral surgery for oropharyngeal carcinoma. , 2019, Oral oncology.

[18]  E. Genden,et al.  Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial. , 2019, Oral oncology.

[19]  E. Vokes,et al.  OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  N. Futran,et al.  Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). , 2018, Oral oncology.

[21]  A. Chaturvedi,et al.  A snapshot of the evolving epidemiology of oropharynx cancers , 2018, Cancer.

[22]  C. Lohse,et al.  Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes , 2018, Head & neck.

[23]  F. Civantos,et al.  Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus , 2018, Head & neck.

[24]  P. Blanchard,et al.  Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand? , 2017, Clinical and translational radiation oncology.

[25]  Andrew D. Palmer,et al.  Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer , 2017, JAMA otolaryngology-- head & neck surgery.

[26]  H. Shukla,et al.  Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial. , 2017, Oral oncology.

[27]  B. O'Sullivan,et al.  Overview of the 8th Edition TNM Classification for Head and Neck Cancer , 2017, Current Treatment Options in Oncology.

[28]  V. Tombolini,et al.  Definitive Intensity-modulated Radiation Therapy in Elderly Patients with Locally Advanced Oropharyngeal Cancer. , 2017, In vivo.

[29]  M. Goodman,et al.  Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States. , 2016, JAMA oncology.

[30]  E. Sturgis,et al.  Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma , 2016, Head & neck.

[31]  I. Ganly,et al.  Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base , 2016, Cancer.

[32]  A. Levy,et al.  Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives. , 2015, Cancer treatment reviews.

[33]  C. Hurt,et al.  PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer , 2015, BMC Cancer.

[34]  G. Weinstein,et al.  Understanding contraindications for transoral robotic surgery (TORS) for oropharyngeal cancer , 2015, European Archives of Oto-Rhino-Laryngology.

[35]  P. Kerr,et al.  Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy , 2015, Journal of Otolaryngology - Head & Neck Surgery.

[36]  Elizabeth R. Unger,et al.  Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices , 2015, MMWR. Morbidity and mortality weekly report.

[37]  M. Daly,et al.  Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer , 2015, Head & neck.

[38]  Chandra Sekhar Pedamallu,et al.  Characterization of HPV and host genome interactions in primary head and neck cancers , 2014, Proceedings of the National Academy of Sciences.

[39]  E. Sturgis,et al.  Epidemiology of HPV-associated oropharyngeal cancer. , 2014, Oral oncology.

[40]  M. B. Gillespie,et al.  A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. , 2014, JAMA otolaryngology-- head & neck surgery.

[41]  W. Lam,et al.  Comprehensive Analysis of HPV16 Integration in OSCC Reveals No Significant Impact of Physical Status on Viral Oncogene and Virally Disrupted Human Gene Expression , 2014, PloS one.

[42]  Amy Y. Chen,et al.  Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009 , 2014, The Laryngoscope.

[43]  T. Teknos,et al.  Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. , 2013, JAMA otolaryngology-- head & neck surgery.

[44]  R. Pellini,et al.  Transoral robotic surgery (TORS) for tongue base tumours , 2013, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[45]  Young Min Park,et al.  How to optimize laryngeal and hypopharyngeal exposure in transoral robotic surgery. , 2013, Auris, nasus, larynx.

[46]  A. Garden,et al.  Clinical Investigation : Head and Neck Cancer Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy , 2013 .

[47]  F. Feng,et al.  Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. , 2013, International journal of radiation oncology, biology, physics.

[48]  Young Min Park,et al.  Parapharyngeal space surgery via a transoral approach using a robotic surgical system: transoral robotic surgery. , 2013, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[49]  P. Levendag,et al.  The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer , 2013, The Laryngoscope.

[50]  L. Murray,et al.  Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. , 2012, Oral oncology.

[51]  S. Y. Lee,et al.  Robotic sialoadenectomy of the submandibular gland via a modified face-lift approach. , 2012, International journal of oral and maxillofacial surgery.

[52]  G. Weinstein,et al.  Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins , 2012, The Laryngoscope.

[53]  A. El‐Naggar,et al.  p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistency , 2012, Head & neck.

[54]  Todd McNutt,et al.  SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy. , 2011, International journal of radiation oncology, biology, physics.

[55]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[56]  G. Weinstein,et al.  Transoral robotic surgery for advanced oropharyngeal carcinoma. , 2010, Archives of otolaryngology--head & neck surgery.

[57]  Jonathan G. Li,et al.  Intensity‐modulated radiotherapy for oropharyngeal squamous cell carcinoma 1 , 2010, The Laryngoscope.

[58]  C. Moskaluk,et al.  Intensity‐modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status , 2010, Cancer.

[59]  S. Bhide,et al.  Advances in radiotherapy for head and neck cancer. , 2010, Oral oncology.

[60]  Walter R. Bosch,et al.  Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). , 2010, International journal of radiation oncology, biology, physics.

[61]  M. Kaplan,et al.  Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. , 2010, International journal of radiation oncology, biology, physics.

[62]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[63]  E. Taioli,et al.  Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis , 2007, International journal of cancer.

[64]  Margie Hunt,et al.  Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. , 2006, International journal of radiation oncology, biology, physics.

[65]  M. van Glabbeke,et al.  Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.

[66]  J. Laissue,et al.  Human papillomavirus positive squamous cell carcinoma of the oropharynx , 2001, Cancer.

[67]  Suzanne L Wolden,et al.  Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. , 2012, International journal of radiation oncology, biology, physics.

[68]  B. Shyu,et al.  Open Access Research , 2022 .